Several countries around the world are focusing on the development of a new coronavirus vaccine, which is the key to stopping the virus pandemic in the future. The vaccine is not yet complete, but China Electronics Corporation has announced the completion of the world's largest new coronavirus vaccine manufacturing plant, with an annual production capacity of up to 100 million doses.
A subsidiary of China Electronics Corporation (CLP IV), has successfully completed the delivery of the first human P3 biopharmaceutical production plant in China, which is the world's largest production plant for the new coronavirus vaccine, with the capacity to produce 100 million doses of vaccine annually after mass production.
According to reports, CLP IV has been undertaking the general contracting and construction of a number of high-level biosafety vaccine production workshops for the first batch of inactivated whole virus vaccines in China since the Spring Festival, and the vaccine production workshops built this time fill the biosafety gap in the field of vaccines for the prevention and control of major epidemics in China, and are of great significance to the research and development of drugs and vaccines for the pneumonia epidemic.
In the development of new coronavirus vaccines, WHO has announced eight vaccines in clinical trials, of which four are from Chinese companies, three from the US and one from the UK. Among the vaccines in China, some of the inactivated vaccines developed by Tech Bio have been published in trials, proving that the vaccines are safe and effective.
According to the official website, China Electronics Corporation was founded in 1953 and is a subsidiary of CEC, China Electronics Corporation System Technology Co.
Special Report: Fighting The New Coronavirus
